神経障害性疼痛治療の世界市場 2024～2028年

概要

世界の神経障害性疼痛治療の市場規模は、2023年～2028年にかけて58億4,005万米ドル増加し、予測期間中はCAGR 10.96%で成長すると予測されています。

当レポートでは、神経障害性疼痛治療市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。神経障害性疼痛の患者数が多いこと、糖尿病性神経障害性疼痛治療薬の市場開拓に注目が集まっていること、ジェネリック医薬品の浸透が進んでいることなどが市場を牽引しています。

本調査では、市場力学を変化させる神経障害性疼痛治療用局所パッチの開拓が、今後数年間の神経障害性疼痛治療市場成長を牽引する主要因の1つであるとしています。また、新興国への注目の高まりと肥満と内分泌疾患の関連性が市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模の把握

• 市場の定義
• 市場セグメント分析
• 市場規模 2023年
• 市場の見通し 2023～2028年

第4章 市場規模実績

• 神経障害性疼痛治療の世界市場 2018～2022年
• 適応症セグメント分析 2018～2022年
• 流通チャネルセグメント分析 2018～2022年
• 地域別セグメント分析 2018～2022年
• 国別セグメント分析 2018～2022年

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：適応症別

• 市場セグメント
• 比較：適応症別
• 糖尿病性神経障害：市場規模と予測 2023～2028年
• 化学療法誘発性神経障害性疼痛：市場規模と予測 2023～2028年
• 帯状疱疹後神経痛：市場規模と予測 2023～2028年
• その他：市場規模と予測 2023～2028年
• 市場機会：適応症別

第7章 市場セグメンテーション：流通チャネル別

• 市場セグメント
• 比較：流通チャネル別
• 小売薬局：市場規模と予測 2023～2028年
• 病院薬局：市場規模と予測 2023～2028年
• オンライン薬局：市場規模と予測 2023～2028年
• 市場機会：流通チャネル別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023～2028年
• 欧州：市場規模と予測 2023～2028年
• アジア：市場規模と予測 2023～2028年
• その他の地域：市場規模と予測 2023～2028年
• 米国：市場規模と予測 2023～2028年
• ドイツ：市場規模と予測 2023～2028年
• カナダ：市場規模と予測 2023～2028年
• 中国：市場規模と予測 2023～2028年
• 英国：市場規模と予測 2023～2028年
• 市場機会：地域情勢別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 革新の情勢
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Abbott Laboratories
• Astellas Pharma Inc.
• AstraZeneca Plc
• Baxter International Inc.
• Biogen Inc.
• Bristol Myers Squibb Co.
• Daiichi Sankyo Co. Ltd.
• Dr Reddys Laboratories Ltd.
• Eli Lilly and Co.
• Endo International Plc
• Johnson and Johnson
• Pfizer Inc.
• Sanofi
• Sun Pharmaceutical Industries Ltd.
• VistaGen Therapeutics Inc.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Indication
• Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global neuropathy pain treatment market 2018 - 2022 ($ million)
• Exhibits19: Historic Market Size - Indication Segment 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Indication - Market share 2023-2028 (%)
• Exhibits31: Data Table on Indication - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Indication
• Exhibits33: Data Table on Comparison by Indication
• Exhibits34: Chart on Diabetic neuropathy - Market size and forecast 2023-2028 ($ million)
• Exhibits35: Data Table on Diabetic neuropathy - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Chart on Diabetic neuropathy - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Diabetic neuropathy - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Chemotherapy-induced neuropathy pain - Market size and forecast 2023-2028 ($ million)
• Exhibits39: Data Table on Chemotherapy-induced neuropathy pain - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Chart on Chemotherapy-induced neuropathy pain - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Chemotherapy-induced neuropathy pain - Year-over-year growth 2023-2028 (%)
• Exhibits42: Chart on Postherpetic neuralgia - Market size and forecast 2023-2028 ($ million)
• Exhibits43: Data Table on Postherpetic neuralgia - Market size and forecast 2023-2028 ($ million)
• Exhibits44: Chart on Postherpetic neuralgia - Year-over-year growth 2023-2028 (%)
• Exhibits45: Data Table on Postherpetic neuralgia - Year-over-year growth 2023-2028 (%)
• Exhibits46: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits48: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits49: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits50: Market opportunity by Indication ($ million)
• Exhibits51: Data Table on Market opportunity by Indication ($ million)
• Exhibits52: Chart on Distribution Channel - Market share 2023-2028 (%)
• Exhibits53: Data Table on Distribution Channel - Market share 2023-2028 (%)
• Exhibits54: Chart on Comparison by Distribution Channel
• Exhibits55: Data Table on Comparison by Distribution Channel
• Exhibits56: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
• Exhibits57: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
• Exhibits58: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibits59: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibits60: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
• Exhibits61: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
• Exhibits62: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibits63: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibits64: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
• Exhibits65: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
• Exhibits66: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibits67: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibits68: Market opportunity by Distribution Channel ($ million)
• Exhibits69: Data Table on Market opportunity by Distribution Channel ($ million)
• Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits73: Chart on Geographic comparison
• Exhibits74: Data Table on Geographic comparison
• Exhibits75: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits77: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits81: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits85: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits101: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits103: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits104: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits105: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits106: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits107: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits108: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits109: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits110: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits111: Market opportunity By Geographical Landscape ($ million)
• Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits113: Impact of drivers and challenges in 2023 and 2028
• Exhibits114: Overview on Criticality of inputs and Factors of differentiation
• Exhibits115: Overview on factors of disruption
• Exhibits116: Impact of key risks on business
• Exhibits117: Vendors covered
• Exhibits118: Matrix on vendor position and classification
• Exhibits119: Abbott Laboratories - Overview
• Exhibits120: Abbott Laboratories - Business segments
• Exhibits121: Abbott Laboratories - Key news
• Exhibits122: Abbott Laboratories - Key offerings
• Exhibits123: Abbott Laboratories - Segment focus
• Exhibits124: Astellas Pharma Inc. - Overview
• Exhibits125: Astellas Pharma Inc. - Product / Service
• Exhibits126: Astellas Pharma Inc. - Key news
• Exhibits127: Astellas Pharma Inc. - Key offerings
• Exhibits128: AstraZeneca Plc - Overview
• Exhibits129: AstraZeneca Plc - Product / Service
• Exhibits130: AstraZeneca Plc - Key news
• Exhibits131: AstraZeneca Plc - Key offerings
• Exhibits132: Baxter International Inc. - Overview
• Exhibits133: Baxter International Inc. - Business segments
• Exhibits134: Baxter International Inc. - Key news
• Exhibits135: Baxter International Inc. - Key offerings
• Exhibits136: Baxter International Inc. - Segment focus
• Exhibits137: Biogen Inc. - Overview
• Exhibits138: Biogen Inc. - Product / Service
• Exhibits139: Biogen Inc. - Key offerings
• Exhibits140: Bristol Myers Squibb Co. - Overview
• Exhibits141: Bristol Myers Squibb Co. - Product / Service
• Exhibits142: Bristol Myers Squibb Co. - Key news
• Exhibits143: Bristol Myers Squibb Co. - Key offerings
• Exhibits144: Daiichi Sankyo Co. Ltd. - Overview
• Exhibits145: Daiichi Sankyo Co. Ltd. - Product / Service
• Exhibits146: Daiichi Sankyo Co. Ltd. - Key news
• Exhibits147: Daiichi Sankyo Co. Ltd. - Key offerings
• Exhibits148: Dr Reddys Laboratories Ltd. - Overview
• Exhibits149: Dr Reddys Laboratories Ltd. - Business segments
• Exhibits150: Dr Reddys Laboratories Ltd. - Key offerings
• Exhibits151: Dr Reddys Laboratories Ltd. - Segment focus
• Exhibits152: Eli Lilly and Co. - Overview
• Exhibits153: Eli Lilly and Co. - Product / Service
• Exhibits154: Eli Lilly and Co. - Key news
• Exhibits155: Eli Lilly and Co. - Key offerings
• Exhibits156: Endo International Plc - Overview
• Exhibits157: Endo International Plc - Business segments
• Exhibits158: Endo International Plc - Key news
• Exhibits159: Endo International Plc - Key offerings
• Exhibits160: Endo International Plc - Segment focus
• Exhibits161: Johnson and Johnson - Overview
• Exhibits162: Johnson and Johnson - Business segments
• Exhibits163: Johnson and Johnson - Key news
• Exhibits164: Johnson and Johnson - Key offerings
• Exhibits165: Johnson and Johnson - Segment focus
• Exhibits166: Pfizer Inc. - Overview
• Exhibits167: Pfizer Inc. - Product / Service
• Exhibits168: Pfizer Inc. - Key news
• Exhibits169: Pfizer Inc. - Key offerings
• Exhibits170: Sanofi - Overview
• Exhibits171: Sanofi - Business segments
• Exhibits172: Sanofi - Key news
• Exhibits173: Sanofi - Key offerings
• Exhibits174: Sanofi - Segment focus
• Exhibits175: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibits176: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibits177: Sun Pharmaceutical Industries Ltd. - Key offerings
• Exhibits178: VistaGen Therapeutics Inc. - Overview
• Exhibits179: VistaGen Therapeutics Inc. - Product / Service
• Exhibits180: VistaGen Therapeutics Inc. - Key offerings
• Exhibits181: Inclusions checklist
• Exhibits182: Exclusions checklist
• Exhibits183: Currency conversion rates for US$
• Exhibits184: Research methodology
• Exhibits185: Validation techniques employed for market sizing
• Exhibits186: Information sources
• Exhibits187: List of abbreviations

Abstract

The neuropathy pain treatment market is forecasted to grow by USD 5840.05 mn during 2023-2028, accelerating at a CAGR of 10.96% during the forecast period. The report on the neuropathy pain treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the presence of a large patient pool of neuropathy pain, a growing focus on the development of drugs for the treatment of diabetic neuropathy pain, and rising penetration of generic drugs.

Technavio's neuropathy pain treatment market is segmented as below:

By Indication

• Diabetic neuropathy
• Chemotherapy-induced neuropathy pain
• Postherpetic neuralgia
• Others

By Distribution Channel

• Retail pharmacies
• Hospital pharmacies
• Online pharmacies

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the development of topical patches for neuropathy pain treatment changing market dynamics as one of the prime reasons driving the neuropathy pain treatment market growth during the next few years. Also, the growing focus on emerging economies and the association between obesity and endocrine disorders will lead to sizable demand in the market.

The report on the neuropathy pain treatment market covers the following areas:

• Neuropathy pain treatment market sizing
• Neuropathy pain treatment market forecast
• Neuropathy pain treatment market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neuropathy pain treatment market vendors that include Abbott Laboratories, Alfasigma Spa, Astellas Pharma Inc., AstraZeneca Plc, Baxter International Inc., Biogen Inc., Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Endo International Plc, GlaxoSmithKline Plc, Johnson and Johnson, Mallinckrodt Plc, Neuracle Lifesciences Pvt. Ltd., Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Inc., and VistaGen Therapeutics Inc.. Also, the neuropathy pain treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Indication
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global neuropathy pain treatment market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global neuropathy pain treatment market 2018 - 2022 ($ million)
• 4.2 Indication Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Indication Segment 2018 - 2022 ($ million)
• 4.3 Distribution Channel Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Indication

• 6.1 Market segments
• Exhibit 30: Chart on Indication - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Indication - Market share 2023-2028 (%)
• 6.2 Comparison by Indication
• Exhibit 32: Chart on Comparison by Indication
• Exhibit 33: Data Table on Comparison by Indication
• 6.3 Diabetic neuropathy - Market size and forecast 2023-2028
• Exhibit 34: Chart on Diabetic neuropathy - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on Diabetic neuropathy - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on Diabetic neuropathy - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Diabetic neuropathy - Year-over-year growth 2023-2028 (%)
• 6.4 Chemotherapy-induced neuropathy pain - Market size and forecast 2023-2028
• Exhibit 38: Chart on Chemotherapy-induced neuropathy pain - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on Chemotherapy-induced neuropathy pain - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on Chemotherapy-induced neuropathy pain - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Chemotherapy-induced neuropathy pain - Year-over-year growth 2023-2028 (%)
• 6.5 Postherpetic neuralgia - Market size and forecast 2023-2028
• Exhibit 42: Chart on Postherpetic neuralgia - Market size and forecast 2023-2028 ($ million)
• Exhibit 43: Data Table on Postherpetic neuralgia - Market size and forecast 2023-2028 ($ million)
• Exhibit 44: Chart on Postherpetic neuralgia - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Postherpetic neuralgia - Year-over-year growth 2023-2028 (%)
• 6.6 Others - Market size and forecast 2023-2028
• Exhibit 46: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 48: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 49: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 6.7 Market opportunity by Indication
• Exhibit 50: Market opportunity by Indication ($ million)
• Exhibit 51: Data Table on Market opportunity by Indication ($ million)

7 Market Segmentation by Distribution Channel

• 7.1 Market segments
• Exhibit 52: Chart on Distribution Channel - Market share 2023-2028 (%)
• Exhibit 53: Data Table on Distribution Channel - Market share 2023-2028 (%)
• 7.2 Comparison by Distribution Channel
• Exhibit 54: Chart on Comparison by Distribution Channel
• Exhibit 55: Data Table on Comparison by Distribution Channel
• 7.3 Retail pharmacies - Market size and forecast 2023-2028
• Exhibit 56: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
• Exhibit 57: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
• Exhibit 58: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
• 7.4 Hospital pharmacies - Market size and forecast 2023-2028
• Exhibit 60: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
• Exhibit 61: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
• Exhibit 62: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibit 63: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
• 7.5 Online pharmacies - Market size and forecast 2023-2028
• Exhibit 64: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
• Exhibit 65: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
• Exhibit 66: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibit 67: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
• 7.6 Market opportunity by Distribution Channel
• Exhibit 68: Market opportunity by Distribution Channel ($ million)
• Exhibit 69: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 73: Chart on Geographic comparison
• Exhibit 74: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
• Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 Canada - Market size and forecast 2023-2028
• Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.10 China - Market size and forecast 2023-2028
• Exhibit 103: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 104: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 105: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 106: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.11 UK - Market size and forecast 2023-2028
• Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 111: Market opportunity By Geographical Landscape ($ million)
• Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 113: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 115: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 116: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 117: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 118: Matrix on vendor position and classification
• 12.3 Abbott Laboratories
• Exhibit 119: Abbott Laboratories - Overview
• Exhibit 120: Abbott Laboratories - Business segments
• Exhibit 121: Abbott Laboratories - Key news
• Exhibit 122: Abbott Laboratories - Key offerings
• Exhibit 123: Abbott Laboratories - Segment focus
• 12.4 Astellas Pharma Inc.
• Exhibit 124: Astellas Pharma Inc. - Overview
• Exhibit 125: Astellas Pharma Inc. - Product / Service
• Exhibit 126: Astellas Pharma Inc. - Key news
• Exhibit 127: Astellas Pharma Inc. - Key offerings
• 12.5 AstraZeneca Plc
• Exhibit 128: AstraZeneca Plc - Overview
• Exhibit 129: AstraZeneca Plc - Product / Service
• Exhibit 130: AstraZeneca Plc - Key news
• Exhibit 131: AstraZeneca Plc - Key offerings
• 12.6 Baxter International Inc.
• Exhibit 132: Baxter International Inc. - Overview
• Exhibit 133: Baxter International Inc. - Business segments
• Exhibit 134: Baxter International Inc. - Key news
• Exhibit 135: Baxter International Inc. - Key offerings
• Exhibit 136: Baxter International Inc. - Segment focus
• 12.7 Biogen Inc.
• Exhibit 137: Biogen Inc. - Overview
• Exhibit 138: Biogen Inc. - Product / Service
• Exhibit 139: Biogen Inc. - Key offerings
• 12.8 Bristol Myers Squibb Co.
• Exhibit 140: Bristol Myers Squibb Co. - Overview
• Exhibit 141: Bristol Myers Squibb Co. - Product / Service
• Exhibit 142: Bristol Myers Squibb Co. - Key news
• Exhibit 143: Bristol Myers Squibb Co. - Key offerings
• 12.9 Daiichi Sankyo Co. Ltd.
• Exhibit 144: Daiichi Sankyo Co. Ltd. - Overview
• Exhibit 145: Daiichi Sankyo Co. Ltd. - Product / Service
• Exhibit 146: Daiichi Sankyo Co. Ltd. - Key news
• Exhibit 147: Daiichi Sankyo Co. Ltd. - Key offerings
• 12.10 Dr Reddys Laboratories Ltd.
• Exhibit 148: Dr Reddys Laboratories Ltd. - Overview
• Exhibit 149: Dr Reddys Laboratories Ltd. - Business segments
• Exhibit 150: Dr Reddys Laboratories Ltd. - Key offerings
• Exhibit 151: Dr Reddys Laboratories Ltd. - Segment focus
• 12.11 Eli Lilly and Co.
• Exhibit 152: Eli Lilly and Co. - Overview
• Exhibit 153: Eli Lilly and Co. - Product / Service
• Exhibit 154: Eli Lilly and Co. - Key news
• Exhibit 155: Eli Lilly and Co. - Key offerings
• 12.12 Endo International Plc
• Exhibit 156: Endo International Plc - Overview
• Exhibit 157: Endo International Plc - Business segments
• Exhibit 158: Endo International Plc - Key news
• Exhibit 159: Endo International Plc - Key offerings
• Exhibit 160: Endo International Plc - Segment focus
• 12.13 Johnson and Johnson
• Exhibit 161: Johnson and Johnson - Overview
• Exhibit 162: Johnson and Johnson - Business segments
• Exhibit 163: Johnson and Johnson - Key news
• Exhibit 164: Johnson and Johnson - Key offerings
• Exhibit 165: Johnson and Johnson - Segment focus
• 12.14 Pfizer Inc.
• Exhibit 166: Pfizer Inc. - Overview
• Exhibit 167: Pfizer Inc. - Product / Service
• Exhibit 168: Pfizer Inc. - Key news
• Exhibit 169: Pfizer Inc. - Key offerings
• 12.15 Sanofi
• Exhibit 170: Sanofi - Overview
• Exhibit 171: Sanofi - Business segments
• Exhibit 172: Sanofi - Key news
• Exhibit 173: Sanofi - Key offerings
• Exhibit 174: Sanofi - Segment focus
• 12.16 Sun Pharmaceutical Industries Ltd.
• Exhibit 175: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibit 176: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibit 177: Sun Pharmaceutical Industries Ltd. - Key offerings
• 12.17 VistaGen Therapeutics Inc.
• Exhibit 178: VistaGen Therapeutics Inc. - Overview
• Exhibit 179: VistaGen Therapeutics Inc. - Product / Service
• Exhibit 180: VistaGen Therapeutics Inc. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 181: Inclusions checklist
• Exhibit 182: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 183: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 184: Research methodology
• Exhibit 185: Validation techniques employed for market sizing
• Exhibit 186: Information sources
• 13.5 List of abbreviations
• Exhibit 187: List of abbreviations